| Molecular and genetic crosstalks between mTOR and ERRα are key determinants of rapamycin-induced nonalcoholic fatty liver C Chaveroux, LJ Eichner, CR Dufour, A Shatnawi, A Khoutorsky, ... Cell metabolism 17 (4), 586-598, 2013 | 155 | 2013 |
| Enhancement of folate receptor α expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting T Tran, A Shatnawi, X Zheng, KMM Kelley, M Ratnam Cancer research 65 (10), 4431-4441, 2005 | 74 | 2005 |
| C/EBPα redirects androgen receptor signaling through a unique bimodal interaction J Zhang, M Gonit, MD Salazar, A Shatnawi, L Shemshedini, R Trumbly, ... Oncogene 29 (5), 723-738, 2010 | 41 | 2010 |
| R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism A Shatnawi, T Tran, M Ratnam Molecular Endocrinology 21 (3), 635-650, 2007 | 38 | 2007 |
| ELF3 is a repressor of androgen receptor action in prostate cancer cells A Shatnawi, JD Norris, C Chaveroux, JS Jasper, AB Sherk, DP McDonnell, ... Oncogene 33 (7), 862-871, 2014 | 34 | 2014 |
| Hormone depletion-insensitivity of prostate cancer cells is supported by the AR without binding to classical response elements M Gonit, J Zhang, MA Salazar, H Cui, A Shatnawi, R Trumbly, M Ratnam Molecular Endocrinology 25 (4), 621-634, 2011 | 33 | 2011 |
| Estrogen-induced and TAFII30-mediated gene repression by direct recruitment of the estrogen receptor and co-repressors to the core promoter and its reversal by tamoxifen H Hao, M d'Alincourt-Salazar, KMM Kelley, A Shatnawi, S Mukherjee, ... Oncogene 26 (57), 7872-7884, 2007 | 30 | 2007 |
| A qualitative assessment of West Virginia pharmacist activities and attitude in diabetes management A Shatnawi, DA Latif Journal of Evaluation in Clinical Practice 23 (3), 586-592, 2017 | 15 | 2017 |
| Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemia HE Carraway, SA Malkaram, Y Cen, A Shatnawi, J Fan, HEA Ali, ... Scientific reports 10 (1), 10325, 2020 | 14 | 2020 |
| A comparative study of the depth, breadth, and perception of pharmacogenomics instruction in a subgroup of US pharmacy curricula A Shatnawi, NM Khanfar, DA Latif, M Shear Currents in Pharmacy Teaching and Learning 11 (5), 476-484, 2019 | 14 | 2019 |
| Pharmacogenomics instruction depth, extent, and perception in US medical curricula D Basyouni, A Shatnawi Journal of Medical Education and Curricular Development 7, 2382120520930772, 2020 | 13 | 2020 |
| Induction of folate receptor type β in a bone marrow engraftment model of acute myelogenous leukemia BW Blaser, M Gonit, H Qi, A Shatnawi, M Guimond, RJ Lee, M Ratnam Leukemia 21 (10), 2233-2235, 2007 | 12 | 2007 |
| ING4 expression landscape and association with clinicopathologic characteristics in breast cancer A Shatnawi, NM Ayoub, AE Alkhalifa Clinical Breast Cancer 21 (4), e319-e331, 2021 | 7 | 2021 |
| Roles of the tumor suppressor inhibitor of growth family member 4 (ING4) in cancer A Shatnawi, DIA Rabe, DE Frigo Advances in Cancer Research 152, 225-262, 2021 | 5 | 2021 |
| Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy A Shatnawi, SA Malkaram, T Fandy, E Tsouko Molecular and Cellular Biochemistry 464 (1), 153-167, 2020 | 3 | 2020 |
| Pharmacogenomics of lipid-lowering agents: the impact on efficacy and safety A Shatnawi, Z Kamran, Q Al-Share Personalized Medicine 20 (1), 65-86, 2023 | 2 | 2023 |
| Estrogen-Related Receptors Gene Expression and Copy Number Alteration Association With the Clinicopathologic Characteristics of Breast Cancer A Shatnawi, NM Ayoub, AE Alkhalifa, DR Ibrahim Breast Cancer: Basic and Clinical Research 16, 11782234221086713, 2022 | 2 | 2022 |
| Differential histone posttranslational modifications induced by DNA hypomethylating agents SA Malkaram, A Shatnawi, J Fan, H Carraway, J Denvir, DA Primerano, ... Cancer Control 29, 10732748221074051, 2022 | 1 | 2022 |
| Impact of Gender Identification on Student Attitudes Towards Providing Care to COVID-19 Patients OF Attarabeen, FM Alkhateeb, A Hanif, A Shatnawi, N Khanfar American Journal of Pharmaceutical Education 87 (8), 2023 | | 2023 |
| Adverse drug reactions (ADRs) case studies: Moderate ADRs M Rashrash, S Schliesser, A Shatnawi, S Sawesi, Q Al-Share Clinical Case Studies on Medication Safety, 33-80, 2023 | | 2023 |
